# Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

> **NCT00790322** · PHASE3 · COMPLETED · sponsor: **Biotec Pharmacon ASA** · enrollment: 130 (actual)

## Conditions studied

- Head and Neck Cancer
- Oral Mucositis

## Interventions

- **DRUG:** SBG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00790322
- **Lead sponsor:** Biotec Pharmacon ASA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2010-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790322, "Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00790322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*